Primary Site >> Colorectal Cancer
Gene >> NT5E
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Two new cytotoxic ent-clerodane diterpenoids from Scutellaria barbata. PMID: 20924899 Ref: Reduced CD73 expression and its association with altered purine nucleotide metabolism in colorectal cancer cells robustly causing liver metastases. PMID: 22966321 |
Ref: CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis. PMID: 21292811 |
Ref: High expression of CD73 as a poor prognostic biomarker in human colorectal cancer. PMID: 22287455 Ref: Characterization of the antiproliferative activity of Xylopia aethiopica. PMID: 22409878 Ref: CD73 as a novel prognostic biomarker for human colorectal cancer. PMID: 22585744 |
Ref: Ensemble of gene signatures identifies novel biomarkers in colorectal cancer activated through PPARgamma and TNFalpha signaling. PMID: 24133572 |
Ref: Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression? PMID: 24213679 Ref: Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis. PMID: 24741617 |
Ref: Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer. PMID: 26427914 |
Ref: Effects of CD73 on human colorectal cancer cell growth in vivo and in vitro. PMID: 26708311 Ref: MicroRNA-187, a downstream effector of TGFbeta pathway, suppresses Smad-mediated epithelial-mesenchymal transition in colorectal cancer. PMID: 26820227 Ref: Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer. PMID: 27006653 Ref: Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer. PMID: 27339628 Ref: Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance). PMID: 27465221 Ref: Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment Regimen. PMID: 27496709 |
Ref: MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73. PMID: 28464916 Ref: Fasting inhibits colorectal cancer growth by reducing M2 polarization of tumor-associated macrophages. PMID: 29088814 |